MarketPeel
Insider Trading Intelligence
Pricing
…
AA

Alan H. Auerbach

PBYI
PRESIDENT AND CEO · PUMA BIOTECHNOLOGY, INC. · CIK 0001358285
FILING MIX · LIFETIME27%/73%
BUYS
18
SELLS
48
TOTAL VALUE
$9.44M
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
7,261,671
AVG SELL PX
$5.05
TRADE KIND
SHOWING 66 / 66
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
47 backtested trades · 8 horizons · 8 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Alan H. Auerbach, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d47+46.81%+4.15%+0.47%+3.68%+2.03%1.63
14d47+53.19%+3.17%+0.56%+2.62%-4.13%0.99
30d47+55.32%+1.54%+1.01%+0.53%-4.68%0.16
60d47+55.32%+1.85%+1.54%+0.31%-5.70%0.07
90d47+63.83%+1.08%+2.35%-1.27%-7.21%-0.26
180d47+51.06%+0.14%+6.97%-6.82%-6.86%-1.08
1y47(2 pending)+55.56%-3.51%+15.18%-18.69%-30.33%-2.21
2y47(6 pending)+68.29%-21.77%+27.51%-49.27%-68.40%-4.44
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PBYI · 7,261,671 shares · as of Jul 6, 2026
01,826,4323,652,8655,479,2977,305,729202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 18 buys / 48 sellsCOVERAGE · 27 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
44,058$8.26$364.1K7,261,671Jul 6, 2026Jul 8, 2026 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
227,474——227,474Feb 18, 2026Feb 20, 2026 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
159,778——7,305,729Feb 18, 2026Feb 20, 2026 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
18,012$5.88$105.9K7,145,951Jan 7, 2026Jan 8, 2026 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
16,938$5.84$99.0K7,163,963Jan 6, 2026Jan 8, 2026 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
21,580$3.54$76.3K7,180,901Jul 9, 2025Jul 10, 2025 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
25,592$3.53$90.4K7,202,481Jul 8, 2025Jul 10, 2025 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
198,399——7,228,073Feb 7, 2025Feb 11, 2025 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
274,622——274,622Feb 7, 2025Feb 11, 2025 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
33,841$3.15$106.7K7,029,674Jan 2, 2025Jan 3, 2025 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
21,920$3.70$81.1K7,063,515Jul 17, 2024Jul 18, 2024 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
18,885$3.27$61.7K7,085,435Jul 2, 2024Jul 2, 2024 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
6,577——7,104,320Mar 15, 2024Mar 19, 2024 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
9,047——9,047Mar 15, 2024Mar 19, 2024 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
222,573——222,573Feb 12, 2024Feb 14, 2024 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
160,796——7,097,743Feb 12, 2024Feb 14, 2024 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
41,396$4.49$185.7K6,936,947Jan 3, 2024Jan 5, 2024 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
258,924——258,924Feb 10, 2023Feb 14, 2023 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
186,403——7,039,041Feb 10, 2023Feb 14, 2023 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
President and CEO
27,241$4.18$113.8K6,852,638Jan 3, 2023Jan 5, 2023 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
568,181$4.40$2.50M6,879,879Dec 12, 2022Dec 12, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
President and CEO
1,251$4.50$5.6K6,311,698Dec 2, 2022Dec 6, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
President and CEO
1,242$2.25$2.8K6,312,949Nov 2, 2022Nov 4, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
President and CEO
1,260$2.34$2.9K6,314,191Oct 3, 2022Oct 5, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
President and CEO
1,254$2.59$3.2K6,315,451Sep 2, 2022Sep 7, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
President and CEO
1,247$2.89$3.6K6,316,705Aug 2, 2022Aug 4, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
President and CEO
26,140$2.63$68.8K6,317,952Jul 5, 2022Jul 7, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
President and CEO
1,200$1.94$2.3K6,344,092Jun 2, 2022Jun 6, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
President and CEO
1,263$2.32$2.9K6,345,292May 3, 2022May 4, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
President and CEO
1,198$3.08$3.7K6,346,555Apr 4, 2022Apr 5, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
1,792,114$2.79$5.00M6,347,753Mar 10, 2022Mar 14, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
168,824——4,555,639Mar 3, 2022Mar 14, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
241,176——241,176Mar 3, 2022Mar 14, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
President and CEO
1,294$2.26$2.9K4,386,815Mar 2, 2022Mar 4, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
President and CEO
1,316$2.46$3.2K4,388,109Feb 2, 2022Feb 3, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
President and CEO
22,875$3.19$72.9K4,389,425Jan 3, 2022Jan 5, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
President and CEO
1,837$2.90$5.3K4,412,300Dec 2, 2021Dec 6, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
1,795$5.63$10.1K4,414,137Nov 2, 2021Nov 3, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
President and CEO
1,858$6.15$11.4K4,415,932Oct 4, 2021Oct 6, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
1,764$7.60$13.4K4,417,790Sep 2, 2021Sep 3, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
1,764$7.53$13.3K4,419,554Aug 2, 2021Aug 3, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
5,332$8.84$47.1K4,421,318Jul 2, 2021Jul 6, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
1,757$10.74$18.9K4,426,650Jun 2, 2021Jun 4, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
1,758$9.01$15.8K4,428,407May 3, 2021May 5, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
1,584$9.80$15.5K4,430,165Apr 5, 2021Apr 6, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
1,238$10.14$12.6K4,431,749Mar 2, 2021Mar 4, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
149,951——4,432,987Feb 17, 2021Feb 19, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
210,944——210,944Feb 17, 2021Feb 19, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
1,222$12.22$14.9K4,283,036Feb 2, 2021Feb 3, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
18,235$10.22$186.4K4,284,258Jan 4, 2021Jan 6, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
355$11.66$4.1K4,302,493Dec 2, 2020Dec 4, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
371$7.82$2.9K4,302,848Nov 2, 2020Nov 3, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
350$10.13$3.5K4,303,219Oct 2, 2020Oct 5, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
347$9.78$3.4K4,303,569Sep 2, 2020Sep 3, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
330$10.79$3.6K4,303,916Aug 3, 2020Aug 5, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
2,607$10.66$27.8K4,304,246Jul 2, 2020Jul 6, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
100$10.70$1.1K4,307,095Jun 2, 2020Jun 3, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
242$10.71$2.6K4,306,853Jun 2, 2020Jun 3, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
339$9.70$3.3K4,307,195May 4, 2020May 6, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
347$7.39$2.6K4,307,534Apr 2, 2020Apr 3, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
372$10.02$3.7K4,307,881Mar 2, 2020Mar 3, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
161,649——161,649Feb 11, 2020Feb 13, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
127,553——4,308,253Feb 11, 2020Feb 13, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
331$8.01$2.7K4,180,700Feb 3, 2020Feb 4, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
43$8.32$3584,187,004Jan 2, 2020Jan 3, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
PRESIDENT AND CEO
5,973$8.39$50.1K4,181,031Jan 2, 2020Jan 3, 2020 ↗View →
Other insiders · PBYI
Loading peer insiders…
About this filer
CIK 0001358285
ROLE
PRESIDENT AND CEO
PRIMARY
PBYI
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001358285DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback